Full Text View
Tabular View
No Study Results Posted
Related Studies
Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes (REMIND™)
This study has been completed.
Study NCT01180530   Information provided by Novo Nordisk

First Received on August 6, 2010.   Last Updated on June 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Diabetes Mellitus, Type 1
Delivery Systems
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
NovoPen Echo®
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services